medigraphic.com
Instituto Nacional de Salud Pública

2009, Number 6

<< Back Next >>

salud publica mex 2009; 51 (6)

Incidence of myocardial infarction in low-income urban residents of Mexico City

Jiménez-Corona A, López-Ridaura R, González-Villalpando C

Language: Spanish
References: 30
Page: 458-464
PDF size: 130.38 Kb.


ABSTRACT

Objective. To estimate the incidence of myocardial infarction (MI) in a low-income Mexican population. Material and Methods. A total of 1 696 men and women aged 35 to 64 years from a longitudinal study were included. All subjects were free of MI at baseline. Incident MI was diagnosed during follow-up by electrocardiogram or by death certificate. Multiple logistic regression was used to estimate the risk of MI. Results. Median follow-up was 6.2 years. Sixty-two of the participants developed MI. Age-adjusted incidence of MI was 6.6 in men and 4.8 in women per 1 000 person-years. The risk of developing MI was associated diabetes (OR= 2.42, p= 0.003), systolic blood pressure (OR= 1.28 per10 mm Hg, p= 0.013) and serum cholesterol (OR= 1.36 per 50 mg/dL, p= 0.038). Conclusions. Incidence of MI in this population may be explained by the rising prevalence of diabetes and hypercholesterolemia. It is necessary to implement preventive measures to address those risk factors.


REFERENCES

  1. Kirchhoff M, Davidsen M, Brønnum-Hansen H, Hansen B, Schnack H, Eriksen LS, et al. Incidence of myocardial infarction in the Danish MONICA population 1982-1991. Int J Epidemiol 1999; 28:211-218

  2. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, et al. ARIC. Risk factors for coronary disease in African-Americans. The Atherosclerosis Risk in Communities Study 1987-1997. Arch Intern Med 2002; 162:2565-2571

  3. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies. Diabetes Care 2000;23:962-968

  4. Pérez G, Pena A, Sala J, Roset P, Masiá R, Marrugat J. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators. Int J Epidemiol 1998; 27:599-604

  5. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 24:861-867

  6. Stern MP, Gonzalez C, Mitchell BD, Villalpando E, Haffner SM, Hazuda HP. Genetic and environmental determinants of type II diabetes in Mexico City and San Antonio. Diabetes 1992; 41:484-492

  7. 7.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572

  8. World Health Organization Study Group on Diabetes Mellitus. Diabetes Mellitus. WHO Technical Reports No.127. Geneva, Switzerland: WHO, 1985.

  9. Prineas R, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wrigth-PSG, Inc, 1982.

  10. Organizacion Panamericana de la Salud. Clasificacion Estadistica Internacional de Enfermedades y Problemas Relacionados con la Salud. Scientific Publication 554. 10ed, 3 vols. Washington DC:OPS, 1995.

  11. Haffner SM, Stern MP, Gonzalez-Villalpando C. A Prospective analysis of the HOMA model: The Mexico City Diabetes Study. Diabetes Care 1996; 19:1138-1141

  12. Gonzalez-Villalpando C, Stern MP, Villalpando E. Prevalence of diabetes and glucose intolerance in an urban population at a low-economic level. Rev Invest Clin 1992 44:321-28

  13. Haffner S, Gonzalez-Villalpando C, Hazuda HP. Prevalence of hypertension in Mexico City and San Antonio, Texas. Circulation 1994; 90:1542-1549

  14. Gonzalez-Villalpando C, Stern MP, Arredondo-Perez B. Undiagnosed hypercholesterolemia: A serious health challenge. The Mexico City Diabetes Study. Arch Med Res 1996; 27:19-23

  15. Velazquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A. Prevalence and interrelations of non-communicable chronic diseases and cardiovascular risk factors in Mexico. Final outcomes from the National Health Survey 2000 Arch Cardiol Mex 2003; 73:62-77

  16. Mitchell BD, González Villalpando C,Arredondo Pérez B, García MS, Valdez R, Stern MP. Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vasc Biol 1995;15:721-725.

  17. Velazquez-Monroy O, Velásquez-Monroy O, Barinagarrementería- Aldatz FS, Rubio-Guerra AF, Verdejo J, Méndez-Bello MA, et al. Morbilidad y mortalidad de la enfermedad isquémica del corazón y cerebrovascular en Mexico. 2005. Arch Cardiol Mex 2007; 77:31-39

  18. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years an older. Diabetes 2003; 52:1210-1214

  19. Mitchell BD, Stern MP, Haffner SM. Risk factors for cardiovascular mortality in Mexican-Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 1990;131:423-433.

  20. Greenlee RT, Naleway AL, Vidaillet H. Incidence of myocardial infarction in a general population: The Marshfield Epidemiologic Study Area. WMJ 2002;101:46-52.

  21. Bobak M, Hense HW, Kark J, Kuch B, Vojtisek P, Sinnreich R, et al. An ecological study of determinants of coronary heart disease rates: A comparison of Czech, Bavarian and Israeli men. Int J Epidemiol 1999; 28: 437-444

  22. Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankow JS. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 2003;26:2777-2784

  23. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impactof major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med 1998; 158: 2007-2014

  24. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316:823-828

  25. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci 2001;101-671-379

  26. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE. Diabetes and all-cause mortality and coronary heart disease mortality among US male physicians. Arch Intern Med 2001;161:242-247

  27. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234

  28. Neaton J, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. The Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992;152:56-64.

  29. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity is an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in The Framingham Heart Study. Circulation 1983; 67:968-977

  30. Sievers ML, Bennett PH, Roumain J, Nelson RG. Effect of hypertension on mortality in Pima Indians. Circulation 1999;100:33-40




2020     |     www.medigraphic.com